about
Triumphs, trials, and tribulations of the global response to MERS coronavirusOn the cutting edge of obstructive sleep apnoea: where next?Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort studyRestricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trialE-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysisRespiratory risks from household air pollution in low and middle income countriesRapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective studyCalling the shotsGenetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.Enhancing preparedness for tackling new epidemic threats.Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.Human infection with avian influenza A H6N1 virus: an epidemiological analysis.The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.Newborn screening for cystic fibrosis.Serotherapy for patients with severe influenza.Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract.Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trialsProgress in tuberculosis vaccine development and host-directed therapies--a state of the art review.Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study.Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET studyAnti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.Do art lovers make better doctors?Respiratory implications of a changing climate.Polygenic risk and the development and course of asthma: an analysis of data from a four-decade longitudinal studySubphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.Dangers and opportunities of guidelines in the data-free zone.BMPR2 revisited: are bigger data better?BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisData security in the brave new world of eHealth.Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.Engineering controls are the most protective means of controlling respirable coal mine dust.Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.Hitting home with technology development for asthma.Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
P1433
Q26285248-E89959E5-95BE-4E7B-9E05-513D955771B6Q28081330-2A8E850C-FB25-4836-9198-E2BFED1D07FFQ28267175-C92EE023-1277-495B-9700-9949E0DC437FQ28270112-12D04D43-BFE1-4E3B-B9F7-AE5E4AB266F0Q28272129-29809C8E-7ED2-47D0-8F8C-01F7ADD5EC24Q28391847-8B6B3D0F-CCF2-45B2-BF52-4A219E0264BEQ28603336-96673E19-8648-4872-AC15-765AB7C81AA4Q28729766-F8B60B51-6127-4157-8917-B53504BEBFB1Q28943525-75D4DB2B-B3E4-486F-B704-CE67D7E4F2FFQ29416987-E761CB44-63B4-4A0F-BA85-829B30EB5EF1Q30148632-6ECFB8D7-909D-40CA-AB17-B80D6A5356F6Q30202827-769516E5-90CD-428B-AD79-5C02986B02E7Q30217355-D325B7BB-8D24-4306-9562-25B8F9C1C872Q30235074-CF1C7D0A-41F4-489B-B827-0EBD4D8093DBQ30251641-8BC77434-9E27-48BC-B0CC-85FDBAF0268AQ30252378-B9FED3CC-DF19-4D48-B0A0-1485BCB93203Q30358297-F9B97331-A4A4-4929-9D2A-4DC747CC8C9AQ30359367-E6D33714-4F48-41E7-8F71-3A3D853F3B3FQ30361227-4505F76A-FC05-4A6A-AA80-6D7053A85B76Q30361230-7ACECE8A-C8CB-4FA0-A587-888ABE972224Q30362392-9B57B591-AB30-4DB9-B15F-08D4FF28046BQ30384494-6E5CA7D8-A71D-4987-8FC5-7DF255B6FFD5Q30412203-5A266998-AA3A-440D-BE78-A9190F3ED889Q30560501-78E7DCBA-F4CF-4ED3-A109-202D092A96DBQ30734374-3BCD2610-053F-4784-858E-E52AE5F26795Q30734382-9E9C7BE9-7E93-4903-868C-C7F6A356D1E6Q30826105-D1D1F667-801E-479C-8838-FEDD92A39904Q30901894-C889F064-AE43-470B-A529-90024B91271CQ30933471-F55C5699-023F-46F5-B7F2-22FC1E4C6D2DQ30955660-C50A8337-204D-4940-B54A-A8E35D110CCBQ30957572-C26DF976-C15D-46EE-9DD1-361148053627Q30981295-3F17FF59-B715-4A96-BC5B-24172294FCAEQ31038850-089A2D54-265B-4FC7-A6CE-9FF831B5A37EQ31038854-5897CD46-CB11-4C52-A777-E3F6784D72E3Q31121021-9E06C371-5804-4E94-9FE8-D8B1A0B5536EQ31161295-EA0BC41C-ACCF-47CD-9994-A3DDFEA9C258Q33113006-EC8EE560-3DE0-41A8-ABE7-4D004EFDE1A0Q33434238-8C13A5A5-CE05-46E3-8C6A-908B55DEBCEAQ33446439-901DAECF-9E25-4963-AE1C-5463F302DE00Q33739535-73642B4B-605A-41C4-A9A4-72389096FE25
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
The Lancet. Medicina respiratoria
@it
The Lancet. Respiratory medicine
@ast
The Lancet. Respiratory medicine
@en
The Lancet. Respiratory medicine
@es
The Lancet. Respiratory medicine
@nl
type
label
The Lancet. Medicina respiratoria
@it
The Lancet. Respiratory medicine
@ast
The Lancet. Respiratory medicine
@en
The Lancet. Respiratory medicine
@es
The Lancet. Respiratory medicine
@nl
altLabel
Lancet Respir Med
@en
prefLabel
The Lancet. Medicina respiratoria
@it
The Lancet. Respiratory medicine
@ast
The Lancet. Respiratory medicine
@en
The Lancet. Respiratory medicine
@es
The Lancet. Respiratory medicine
@nl
P3181
P1055
P1058
P1156
21100220495
P123
P1250
P1277
P1476
The Lancet. Respiratory medicine
@en